Tumor endothelial cell-mediated antigen-specific T-cell suppression via the PD-1/PD-L1 pathway

被引：0
|
作者：
Taguchi, Kazuhiro [1 ]
Onoe, Takashi [1 ]
Tashiro, Hirotaka
Ohdan, Hideki
机构：
[1] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OJ12-1-6
引用
收藏
页码：402 / 402
页数：1
相关论文
共 50 条
  • [21] Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation
    Kuipers, Harmjan
    Muskens, Femke
    Willart, Monique
    Hijdra, Danielle
    van Assema, Friso B. J.
    Coyle, Anthony J.
    Hoogsteden, Henk C.
    Lambrecht, Bart N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (09) : 2472 - 2482
  • [22] T-Cell Engagers Based Bioassay for Evaluation of PD-1/PD-L1 Inhibitors Activity
    A. N. Doronin
    A. A. Gordeev
    A. E. Kozlov
    Ya. A. Smirnova
    M. Yu. Puchkova
    V. M. Ekimova
    Yu. I. Basovskiy
    V. V. Solovyev
    Biochemistry (Moscow), 2019, 84 : 711 - 719
  • [23] Blockade of PD-1/PD-L1 Promotes Adoptive T-Cell Immunotherapy in a Tolerogenic Environment
    Blake, Stephen J. P.
    Ching, Alan L. H.
    Kenna, Tony J.
    Galea, Ryan
    Large, Justin
    Yagita, Hideo
    Steptoe, Raymond J.
    PLOS ONE, 2015, 10 (03):
  • [24] T-Cell Engagers Based Bioassay for Evaluation of PD-1/PD-L1 Inhibitors Activity
    Doronin, A. N.
    Gordeev, A. A.
    Kozlov, A. E.
    Smirnova, Ya. A.
    Puchkova, M. Yu.
    Ekimova, V. M.
    Basovskiy, Yu. I.
    Solovyev, V. V.
    BIOCHEMISTRY-MOSCOW, 2019, 84 (07) : 711 - 719
  • [25] Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
    Kotanides, Helen
    Li, Yiwen
    Malabunga, Maria
    Carpenito, Carmine
    Eastman, Scott W.
    Shen, Yang
    Wang, George
    Inigo, Ivan
    Surguladze, David
    Pennello, Anthony L.
    Persaud, Krishnadatt
    Hindi, Sagit
    Topper, Michael
    Chen, Xinlei
    Zhang, Yiwei
    Bulaon, Danielle K.
    Bailey, Tim
    Lao, Yanbin
    Han, Bing
    Torgerson, Stacy
    Chin, Darin
    Sonyi, Andreas
    Haidar, Jaafar N.
    Novosiadly, Ruslan D.
    Moxham, Christopher M.
    Plowman, Gregory D.
    Ludwig, Dale L.
    Kalos, Michael
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (10) : 1300 - 1310
  • [26] PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma
    Jalili-Nik, Mohammad
    Soltani, Arash
    Mashkani, Baratali
    Rafatpanah, Houshang
    Hashemy, Seyed Isaac
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [27] The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
    Brusa, Davide
    Serra, Sara
    Coscia, Marta
    Rossi, Davide
    D'Arena, Giovanni
    Laurenti, Luca
    Jaksic, Ozren
    Fedele, Giorgio
    Inghirami, Giorgio
    Gaidano, Gianluca
    Malavasi, Fabio
    Deaglio, Silvia
    HAEMATOLOGICA, 2013, 98 (06) : 953 - 963
  • [28] Inhibition of T-cell-mediated immune response via the PD-1/PD-L1 axis in cholangiocarcinoma cells
    Suriyo, Tawit
    Fuangthong, Mayuree
    Artpradit, Charlermchai
    Ungtrakul, Teerapat
    Sricharunrat, Thaniya
    Taha, Fatma
    Satayavivad, Jutamaad
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 897
  • [29] A snapshot of the PD-1/PD-L1 pathway
    Ghosh, Chinmoy
    Luong, Gary
    Sun, Yue
    JOURNAL OF CANCER, 2021, 12 (09): : 2735 - 2746
  • [30] Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells
    J J Pen
    B D Keersmaecker
    C Heirman
    J Corthals
    T Liechtenstein
    D Escors
    K Thielemans
    K Breckpot
    Gene Therapy, 2014, 21 : 262 - 271
12345